Showing results (81-90 of 497) with videos related to

Sort By:
Pageof 50
Future Oncology (London, England)|April 29, 2026
Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancerNeal D Shore, Nasreen Khan, Rana R McKay, et al.
Molecular Pharmaceutics|February 19, 2020
Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging AgentJordan M White, Akhila N Kuda-Wedagedara, Madison N Wicker, et al.
Expert Review of Anticancer Therapy|May 17, 2023
Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic reviewKanchi Patell, Matthew Kurian, Jorge A Garcia, et al.
JCO Oncology Practice|May 20, 2025
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of ChangeGianna J Dafflisio, Ming Wang, Xi Wang, et al.
European Urology|August 16, 2016
Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node CoverageDaniel E Spratt, Hebert A Vargas, Zachary S Zumsteg, et al.
The Journal of Urology|July 14, 2015
Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate CancerZachary S Zumsteg, Daniel E Spratt, Paul B Romesser, et al.
Tumori|March 23, 2016
Risk stratification system and pattern of relapse in patients treated with adjuvant radiotherapy after radical prostatectomyMario Levis, Alessia Guarneri, Niccolò Giaj Levra, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
BJU International|January 23, 2014
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancerDaniel E Spratt, Zachary S Zumsteg, Pirus Ghadjar, et al.
Medical Oncology (Northwood, London, England)|February 8, 2020
Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue ProgramRahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Pageof 50